Table 1. Correlation between ZFAS1 level in tissues and clinicopathologic of GC.

Feature	No. of cases	Mean ± SD	P
Age
≥60	34	0.0787 ± 0.0526	0.2621
< 60	32	0.1196 ± 0.1174
Gender
Male	38	0.0814 ± 0.0668	0.5168
Female	28	0.0676 ± 0.1158
Cancer location			0.9979
Distal	18	0.1008 ± 0.0976
Middle	33	0.0885 ± 0.0861
Proximal	35	0.0953 ±0.0998
Diameter (cm)
≥5	25	0.1220 ± 0.0959	0.0209
< 5	41	0.0842 ± 0.0871
Differentiation
Well	6	0.0707 ± 0.0443	0.2012
Moderate	18	0.0707 ± 0.0443
Poor	42	0.1140 ± 0.1079
TNM stage
0, I and II	24	0.0790 ± 0.1060	0.0053**
III, IV	42	0.1097 ± 0.0817
Invasion
T0-T3	6	0.0223 ± 0.0273	0.0043**
T4	60	0.0293 ± 0.0249
Lymph-node metastasis
N0	20	0.0823 ± 0.1145	0.0059**
N1-N3	46	0.1061 ± 0.0792
Distant metastasis
M0	61	0.0972 ± 0.0930	0.4917
M1	5	0.1144 ± 0.0802
CEA
Positive	11	0.0855 ± 0.0485	0.8359
Negative	55	0.1011 ± 0.0982
CA19-9
Positive	15	0.0947 ± 0.0707	0.8886
Negative	51	0.0996 ± 0.0976
Negative	51	0.0996 ± 0.0976